Natixis’s Abbott ABT Stock Holding History

Natixis’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,357	Closed	-$146K	–	1071
2022 Q2	$146K	Buy	+1,357	New	+$154K	﹤0.01%	1045

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Natixis's ABT Position: Q1 2026 in Review

Natixis increased its Abbott (ABT) stake by 171% in Q1 2026, buying an estimated $55.5M and bringing the position to 778,903 shares worth $80M. The position accounts for 0.29% of the portfolio, ranked #48.

Natixis first reported a position in ABT in Q2 2013 and has held it in 39 quarters since. The position peaked at $100M in Q1 2022. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Natixis held 778,903 shares of Abbott worth $80M as of Q1 2026.
Natixis bought 491,506 Abbott shares in Q1 2026, an estimated $55.5M.
Abbott made up 0.29% of Natixis's portfolio in Q1 2026, its #48 holding.
Natixis first reported a position in Abbott in Q2 2013 and has held it in 39 quarters since.
Natixis's Abbott position peaked at $100M in Q1 2022.
3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.